TRIM21 and autoimmune hepatitis: Further screening for ANA profiles and autoimmune liver diseases by immunoblotting revealed that the patient was strongly positive for anti-centromere protein B (anti-CENP B), moderately positive for anti-Ro52 and anti-nucleosome (anti-Nuk), positive for anti-SSA, and weakly positive for anti-gp210 and AMA-M2.